DELTA FORCE is the first head-to-head phase 3 trial comparing a systemic and investigational delgocitinib topical treatment for Chronic Hand Eczema (CHE).1 LEO Pharma A/S, a global leader in ...

DELTA FORCE is the first head-to-head phase 3 trial comparing a ... FORCE data in The Lancet is an exciting moment for the LEO Pharma team," said Robert Spurr, EVP, LEO Pharma, North America ...